H.R. 1262

119th CongressPassed House

Mikaela Naylon Give Kids a Chance Act

Sponsored by Michael T. McCaul (Republican-TX-10)

Healthcare Costs & Access Healthcare & Public Health Health Insurance Coverage

Cosponsors

313

Actions

Roll calls

Amendments

Related bills

Actions

Dec 2, 2025 · Senate

Received in the Senate.

Dec 1, 2025 · House floor actions

Mr. Carter (GA) moved to suspend the rules and pass the bill, as amended.

Dec 1, 2025 · House floor actions

Considered under suspension of the rules. (consideration: CR H4929-4935)

Dec 1, 2025 · House floor actions

DEBATE - The House proceeded with forty minutes of debate on H.R. 1262.

Dec 1, 2025 · Library of Congress

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4929-4932)

Dec 1, 2025 · House floor actions

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4929-4932)

Dec 1, 2025 · House floor actions

Motion to reconsider laid on the table Agreed to without objection.

Oct 31, 2025 · Library of Congress

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-352.

Oct 31, 2025 · House floor actions

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-352.

Oct 31, 2025 · House floor actions

Placed on the Union Calendar, Calendar No. 304.

Sep 17, 2025 · House committee actions

Committee Consideration and Mark-up Session Held

Sep 17, 2025 · House committee actions

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 47 - 0.

Feb 12, 2025 · Library of Congress

Introduced in House

Feb 12, 2025 · Library of Congress

Introduced in House

Feb 12, 2025 · House floor actions

Referred to the House Committee on Energy and Commerce.

Latest activity

Activity

July 2026

Lobbying reported · The Vogel Group · Jul 21

The Vogel Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Fortress Biotech

BillsH.R. 1262

Lobbying reported · Biogen · Jul 20

Biogen reported 2nd Quarter (Apr 1 - June 30) lobbying for Biogen — $1,060,000

BillsH.R. 1262 H.R. 1492 H.R. 3747 H.R. 4317 H.R. 6130 H.R. 6837 S. 832 S. 864 S. 3267 S. 3345

Lobbying reported · Stealth Biotherapeutics · Jul 20

Stealth Biotherapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Stealth Biotherapeutics — $120,000

BillsH.R. 1262 H.R. 4121 H.R. 4709 H.R. 6280 S. 932 S. 2256 S. 3607

Lobbying reported · National Association Of Childrens Hospitals And Affiliates · Jul 20

National Association Of Childrens Hospitals And Affiliates reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association Of Children's Hospitals — $1,370,000

BillsH.R. 169 H.R. 1262 H.R. 1509 H.R. 1735 H.R. 2483 H.R. 2587 H.R. 3505 H.R. 3890 H.R. 4768 H.R. 4798 H.R. 5582 H.R. 6396 S. 357 S. 752 S. 932 S. 2355 S. 2448

Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20

Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000

Lobbying reported · Dana-Farber Cancer Institute · Jul 20

Dana-Farber Cancer Institute reported 2nd Quarter (Apr 1 - June 30) lobbying for Dana-Farber Cancer Institute — $36,000

BillsH.R. 1262 H.R. 1300 H.R. 1509 S. 752

Lobbying reported · Tourette Association Of America · Jul 20

Tourette Association Of America reported 2nd Quarter (Apr 1 - June 30) lobbying for Tourette Association Of America — $60,000

BillsH.R. 1262 H.R. 3514 H.R. 4206 H.R. 5304 H.R. 5509 H.R. 7148 H.R. 9260 S. 932 S. 1261 S. 1816 S. 2587 S. 2903

Lobbying reported · Novartis · Jul 20

Novartis reported 2nd Quarter (Apr 1 - June 30) lobbying for Novartis — $1,410,000

Lobbying reported · Acadia Pharmaceuticals · Jul 20

Acadia Pharmaceuticals reported 2nd Quarter (Apr 1 - June 30) lobbying for Acadia Pharmaceuticals — $700,000

BillsH.R. 1 H.R. 1262 H.R. 1414 H.R. 1492 H.R. 1509 H.R. 3731 H.R. 6130 H.R. 9102 S. 752 S. 832 S. 932 S. 3267

Lobbying reported · Akin Gump Strauss Hauer & Feld · Jul 20

Akin Gump Strauss Hauer & Feld reported 2nd Quarter (Apr 1 - June 30) lobbying for Biotechnology Innovation Organization — $60,000

BillsH.R. 1262 S. 3302

Lobbying reported · Travere Therapeutics · Jul 20

Travere Therapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Travere Therapeutics — $140,000

BillsH.R. 1 H.R. 1262 H.R. 1414 H.R. 1518 H.R. 4709 H.R. 9102 S. 932 S. 1040 S. 2658

Lobbying reported · The Kpm Group DC · Jul 19

The Kpm Group DC reported 2nd Quarter (Apr 1 - June 30) lobbying for Praxis Precision Medicines — $40,000

BillsH.R. 1262 H.R. 1509 S. 752 S. 932

Lobbying reported · Smithbucklin · Jul 17

Smithbucklin reported 2nd Quarter (Apr 1 - June 30) lobbying for Astct — $70,000

BillsH.R. 1262 H.R. 2491 H.R. 3521 H.R. 5160 S. 932 S. 1227 S. 4109 S. 4440

Lobbying reported · Ionis Pharmaceuticals · Jul 17

Ionis Pharmaceuticals reported 2nd Quarter (Apr 1 - June 30) lobbying for Ionis Pharmaceuticals — $150,000

BillsH.R. 1262 H.R. 1414 H.R. 1672 S. 932

Lobbying reported · United Mine Workers Of America · Jul 17

United Mine Workers Of America reported 2nd Quarter (Apr 1 - June 30) lobbying for United Mine Workers Of America — $80,000

BillsH.R. 20 H.R. 1262 H.R. 1700 H.R. 1946 H.R. 2671 H.R. 2692 H.R. 3532 H.R. 4754 H.R. 5304 H.R. 5408 H.R. 5450 H.R. 6756 H.R. 6757 H.R. 6938 H.R. 7147 S. 2431 S. 3293 S. 3491 S. 3505

Lobbying reported · Bridgebio Pharma · Jul 17

Bridgebio Pharma reported 4th Quarter (Oct 1 - Dec 31) lobbying for Bridgebio Pharma — $280,000

BillsH.R. 1 H.R. 1262 S. 932

Lobbying reported · Glaxosmithkline · Jul 16

Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000

Lobbying reported · Bracewell · Jul 16

Bracewell reported 2nd Quarter (Apr 1 - June 30) lobbying for Aquestive Therapeutics — $60,000

BillsH.R. 1262 S. 932

Lobbying reported · Roberti Global · Jul 16

Roberti Global reported 2nd Quarter (Apr 1 - June 30) lobbying for Biotechnology Innovation Organization — $60,000

BillsH.R. 1262 S. 932 S. 2296

Lobbying reported · Bracewell · Jul 16

Bracewell reported 2nd Quarter (Apr 1 - June 30) lobbying for National Brain Tumor Society — $20,000

BillsH.R. 1262 H.R. 2767 S. 1330